Liver Biopsy Needle Market Growth, Trends & Demand by 2034

Coverage: By Product (Disposable Needle, Reusable Needle); End User (Hospital and Clinic, Diagnostic Centers, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00025685
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Liver Biopsy Needle Market Growth, Trends & Demand by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00025685 Email: sales@theinsightpartners.com

2025 Market Size

US$ 165.78 Mn

Base year value

2034 Forecast

US$ 234.16 Mn

Projected by 2034

CAGR 2026-2034

4.41 %

Growth rate

Addressable Market

US$ 1,862.85 Mn

(2026-2034)

The Liver Biopsy Needle Market size is expected to reach US$ 234.16 Million by 2034 from US$ 165.78 Million in 2025. The market is estimated to record a CAGR of 4.41% from 2026 to 2034.

The report is segmented by Product (Disposable Needle, Reusable Needle). Futher, it is segmented based on End User (Hospital and Clinic, Diagnostic Centers, Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.

Purpose of the Report

The report Liver Biopsy Needle Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Liver Biopsy Needle Market Segmentation Product

  1. Disposable Needle
  2. Reusable Needle

End User

  1. Hospital and Clinic
  2. Diagnostic Centers
  3. Others

Market Research Highlights

  • Global market for Liver Biopsy Needle was valued at US$ 165.78 Million in 2025
  • Annual market size is expected to reach US$ 234.16 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 1,862.85 Million
  • Market is anticipated to register a CAGR of 4.41% during the forecast period
  • The United States represents a key market, supported by Rising Incidence of Liver Diseases, Rising Awareness and Screening Programs, Rising Geriatric Population, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Regulatory Developments, Education and Training Programs, Telemedicine Integration are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Zamar Biopsy, Argon, RI.MOS, STERYLAB, Tsunami Medical, HAKKO, CONMED, Medtronic, Merit Medical Systems, Becton Dickinson and Company, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Liver Biopsy Needle Market: Strategic Insights

liver-biopsy-needle-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Liver Biopsy Needle Market Growth Drivers

  1. Rising Incidence of Liver Diseases: A growing concern for rising diseases, such as hepatitis and cirrhosis, fuels the demand for liver biopsy needles. Because diagnosis is crucial for proper treatment, improving instruments will increase demand, thereby expanding the market for such high-tech tools.
  2. Rising Awareness and Screening Programs: Highly conscious awareness of liver health and organized screening programs lead to early diagnosis. Higher public health initiatives and greater educational campaigns have boosted the population base that will need a liver biopsy, hence propelling the liver biopsy needles market.
  3. Rising Geriatric Population: The steadily rising elderly population is suffering from various problems related to liver diseases, creating a high demand for procedures such as liver biopsy. The rising prevalence of age-related liver problems will increase demands in diagnostic technologies like the liver biopsy needle, hence fostering market growth.

Liver Biopsy Needle Market Future Trends

  1. Minimally Invasive Techniques: The trend towards minimally invasive procedures is changing the liver biopsy landscape. New needle designs that reduce trauma and recovery time are emerging, catering to patient preferences for less invasive diagnostic options, hence having a positive influence on the market of a liver biopsy needle.
  2. Integration of AI: AI-based integration in the procedure of liver biopsy is increasingly found. AI algorithms add precision to image-based diagnostics and target accurate needle placement, ensuring a diagnostic result that has a higher precision level. This technological advancement would bring a transformative change to the liver biopsy needle market.
  3. Personalized Medicine: The transition into personal and individual treatment is translating into the biopsy of the liver due to the requirement for detailed diagnostic information. This is forcing advance biopsy needles that facilitate more accurate and individualised assessment of the health condition of the liver.

Liver Biopsy Needle Market Opportunities

  1. Regulatory Developments: Growth in evolving regulatory frameworks is driving the development of safer, more effective liver biopsy devices. Stricter quality standards and higher speed approvals for innovative products will create increasingly dynamic markets, making it an exciting time for industry stakeholders.
  2. Education and Training Programs: Develop educational programs on the latest techniques for performing liver biopsies among healthcare professionals. In this way, there will be some demand for high end biopsy needles. Developing a learning culture would mean improved patient care and sales of new needle products.
  3. Telemedicine Integration: The case of telemedicine offers a chance for remote monitoring and consultation in relation to the liver. Technologies that can be used in incorporating liver biopsy needles into telehealth platforms make it possible to achieve timely diagnostics and treatments, hence expanding the scope of the market.

Liver Biopsy Needle Market Report Scope

Report Attribute Details
Market size in 2025 US$ 165.78 Million
Market Size by 2034 US$ 234.16 Million
Global CAGR (2026 - 2034) 4.41%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Disposable Needle
  • Reusable Needle
By End User
  • Hospital and Clinic
  • Diagnostic Centers
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Zamar Biopsy
  • Argon
  • RI.MOS
  • STERYLAB
  • Tsunami Medical
  • HAKKO
  • CONMED
  • Medtronic
  • Merit Medical Systems
  • Becton Dickinson and Company

Liver Biopsy Needle Market Players Density: Understanding Its Impact on Business Dynamics

The Liver Biopsy Needle Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

liver-biopsy-needle-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Liver Biopsy Needle Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Liver Biopsy Needle Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

North America region accounts for highest revenue share in liver biopsy needle market.

The major factors driving the liver biopsy needle market are:

1. Rising Incidence of Liver Diseases.

2. Rising Awareness and Screening Programs.

The liver biopsy needle market is expected to grow at a CAGR of 4.41% from 2026 to 2034

The final report will duly include market size and projection estimates for all the segments from 2021 to 2034, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2024 are the historic years, 2025 is considered to be the base year, and the forecast will be provided till 2034, along with CAGR of 4.41% from 2026 to 2034

Asia Pacific is estimated to grow at the highest CAGR of 4.41% from 2026 to 2034

CONMED, Medtronic, and Merit Medical Systems are the major companies operating in the liver biopsy needle market.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA